| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 285.16 | 254.00 | 219.35 | 208.48 |
| Sale of Products | 283.46 | 249.09 | 215.50 | 190.90 |
| Sale of Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 243.40 | 261.84 | 238.86 | 133.14 |
| Property, Plant and Equipments | 239.47 | 258.90 | 236.81 | 132.29 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.64 | 0.47 | 0.36 | 0.42 |
| Market Cap (Rs in Crs) | 1,504.01 | |
|---|---|---|
| P/E | 50.75 | |
| Book Value (Rs) | 382.47 | |
| Div (%) | 60 | |
| Market Lot | 1 | |
| EPS (TTM) | 34.84 | |
|---|---|---|
| Price/Book | 4.62 | |
| Div Yield.(%) | 0.34 | |
| Face value (RS) | 10 | |
| Deliverables (%) | 50.17 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 4,20,135.55 | 1,751.05 | 1,692.65 | 3.45 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,49,680.48 | 5,638.35 | 5,757.50 | -2.07 | 6,448.75 - 3,640.10 |
| Cipla Ltd | 1,22,390.34 | 1,515.45 | 1,496.50 | 1.27 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,10,153.97 | 3,254.85 | 3,221.20 | 1.04 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 1,06,554.59 | 2,582.65 | 2,522.45 | 2.39 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 5,91,391 | 6.95 |
| Total Institutions | 1,639 | 0.02 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 2,29,678 | 2.70 |
| Total Promoters | 45,70,944 | 53.73 |
| Total Public & others | 3113213 | 36.59 |
| Total | 85,06,865 | 100 |
